Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 22 , ISSUE 9 ( 2018 ) > List of Articles

BRIEF COMMUNICATION

Diagnostic and Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Early and Late Phase of Sepsis

Madhu Sharma, Nitin Sinha, Rajnish Kaushik, Debraj Jash, Aditya Chaudhry

Keywords : Biomarkers, critical care, diagnostic, inflammatory, sepsis

Citation Information : Sharma M, Sinha N, Kaushik R, Jash D, Chaudhry A. Diagnostic and Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Early and Late Phase of Sepsis. Indian J Crit Care Med 2018; 22 (9):660-663.

DOI: 10.4103/ijccm.IJCCM_59_18

License: CC BY-ND 3.0

Published Online: 01-04-2015

Copyright Statement:  Copyright © 2018; The Author(s).


Abstract

Objective: Early diagnosis of sepsis is necessary to decrease morbidity and mortality. This study aims to evaluate neutrophil-to-lymphocyte ratio (NLR) as diagnostic and prognostic of early and late phase of sepsis. Methods: It was a prospective, observational study, conducted in Intensive Care and High Dependency Unit (Daycare) of the Department of Pulmonary and Critical Care Medicine (tertiary care center), Rohtak, from January 2017 to December 2017. A total of 56 cases of newly diagnosed cases of sepsis were included in the study and 20 healthy adults were taken as controls. Daily NLR was calculated in cases till the primary outcome. Results: The results suggested that NLR seems to have promising role as diagnostic and prognostic marker (with P = 0.001 and P = 0.045, respectively) in sepsis. Conclusion: The study suggests that NLR can be a useful diagnostic and prognostic marker in sepsis.


PDF Share
  1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
  2. Lever A, Mackenzie I. Sepsis: Definition, epidemiology, and diagnosis. BMJ 2007;335:879-83.
  3. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96.
  4. Riché F, Gayat E, Barthélémy R, Le Dorze M, Matéo J, Payen D, et al. Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock. Crit Care 2015;19:439.
  5. De Backer D, Dorman T. Surviving sepsis guidelines: A continuous move toward better care of patients with sepsis. JAMA 2017;317:807-8.
  6. Siqueira-Batista R, Gomes AP, Calixto-Lima L, Vitorino RR, Perez MC, Mendonça EG, et al. Sepsis: An update. Rev Bras Ter Intensiva 2011;23:207-16.
  7. Davis BH. Improved diagnostic approaches to infection/sepsis detection. Expert Rev Mol Diagn 2005;5:193-207.
  8. Peters RP, van Agtmael MA, Danner SA, Savelkoul PH, Vandenbroucke-Grauls CM. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 2004;4:751-60.
  9. de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC, et al. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care 2010;14:R192.
  10. Zahorec R. Ratio of neutrophil to lymphocyte counts — Rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001;102:5-14.
  11. Draft Biomedical Waste (Management and Handling) Rules. New Delhi: Government of India, Ministry of Environment and Forests; 2011. Available from: http://www.moef.nic.in/downloads/public-information/salient-features-draft-bmwmh.pdf. [Last accessed on 2011 Jun 21].
  12. Jilma B, Blann A, Pernerstorfer T, Stohlawetz P, Eichler HG, Vondrovec B, et al. Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med 1999;159:857-63.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.